FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter PROVEPHARM SAS NDA 216264
Letter
NDA 216264
PROVEPHARM SAS
FDA.report
›
FDA Drug Approvals
›
PROVEPHARM SAS
›
NDA 216264
›
Letter
Application #216264
Documents
Letter
2022-07-11
Application Sponsors
NDA 216264
PROVEPHARM SAS
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.